Literature DB >> 9342010

Determination of total cholesterol in serum by liquid chromatography-isotope dilution mass spectrometry.

R Kock1, B Delvoux, H Greiling.   

Abstract

We have developed a liquid chromatography-isotope dilution mass spectrometry procedure to quantify total cholesterol in serum. A particle-beam interface was used for coupling the liquid chromatograph and the mass spectrometer. After electron impact ionization the ions m/z = 386 and m/z = 389 were used for selective ion monitoring of cholesterol and the internal standard [25,26,27-(13)C]cholesterol. The sample preparation steps required for serum materials are alkaline hydrolysis and an extraction of the cholesterol into the cyclohexane phase. Imprecision for the determination of cholesterol in control materials is typically <1.0%. The deviation from the certified reference values was <0.75% for all control materials tested. A method comparison of the results obtained by this method with those obtained by gas chromatography-isotope dilution mass spectrometry for n = 28 pooled human sera derived from samples analyzed in our routine laboratory did not show differences >2.5%.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9342010

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  3 in total

Review 1.  Mass spectrometry techniques in the survey of steroid metabolites as potential disease biomarkers: a review.

Authors:  Maria João Gouveia; Paul J Brindley; Lúcio Lara Santos; José Manuel Correia da Costa; Paula Gomes; Nuno Vale
Journal:  Metabolism       Date:  2013-05-07       Impact factor: 8.694

Review 2.  Analytical methods for cholesterol quantification.

Authors:  Li-Hua Li; Ewelina P Dutkiewicz; Ying-Chen Huang; Hsin-Bai Zhou; Cheng-Chih Hsu
Journal:  J Food Drug Anal       Date:  2018-10-04       Impact factor: 6.157

3.  Innovative Non-Enzymatic Electrochemical Quantification of Cholesterol.

Authors:  Oana Elena Carp; Mariana Pinteala; Adina Arvinte
Journal:  Sensors (Basel)       Date:  2022-01-22       Impact factor: 3.576

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.